Retornaz F, Seux V, Soubeyrand J
Service de médecine interne et gériatrie, CHRU de Marseille, hôpital Sainte-Marguerite, 270, boulevard de Sainte-Marguerite, 13327 Marseille 9, France.
Rev Med Interne. 2004 Dec;25 Suppl 5:S543-51. doi: 10.1016/s0248-8663(04)80053-5.
The term 'primary' osteoporosis refers to osteoporosis that results from the involutional losses associated with aging and, in women, additional losses related to natural menopause. Osteoporosis that is caused or exacerbated by other disorders or medication exposures is referred to as 'secondary' osteoporosis.
This article describes the major causes and provides a framework for the diagnostic investigation of patients with suspected of having secondary osteoporosis. There are numerous causes of secondary bone loss, including endocrine disorders, disorders of the gastrointestinal or biliary tract, rheumatic diseases, haematological diseases, immobilization, adverse effects of drug therapy, and a wide miscellaneous group.
Secondary osteoporosis is potentially reversible during the treatment of the underlying disease. It must be identified and induce a symptomatic treatment in all cases plus an etiologic treatment when possible.
“原发性”骨质疏松症是指由与衰老相关的退行性骨质流失导致的骨质疏松症,在女性中,还包括与自然绝经相关的额外骨质流失。由其他疾病或药物暴露引起或加重的骨质疏松症被称为“继发性”骨质疏松症。
本文描述了主要病因,并为疑似患有继发性骨质疏松症的患者的诊断调查提供了一个框架。继发性骨质流失有多种原因,包括内分泌紊乱、胃肠道或胆道疾病、风湿性疾病、血液系统疾病、制动、药物治疗的不良反应以及一大类杂症。
继发性骨质疏松症在基础疾病治疗期间有可能逆转。在所有病例中都必须识别并进行对症治疗,如有可能还需进行病因治疗。